To B or Not to B: Germinal Center Responses in Progressive Fibrotic Interstitial Lung Disease

Ashten Sherman^{1

2}, Benjamin D Medoff^{3

4}, Josalyn L Cho^{1

2}

Affiliations

¹ Division of Pulmonary, Critical Care, and Occupational Medicine.
² Iowa Inflammation Program University of Iowa Carver College of Medicine Iowa City, Iowa.
³ Division of Pulmonary and Critical Care Medicine.
⁴ Center for Immunology and Inflammatory Diseases Massachusetts General Hospital and Harvard Medical School Boston, Massachusetts.

Editorial

Ashten Sherman et al. Am J Respir Crit Care Med. 2025 Oct.

. 2025 Oct;211(10):1742-1744.

doi: 10.1164/rccm.202508-1969ED.

Ashten Sherman^{1

2}, Benjamin D Medoff^{3

4}, Josalyn L Cho^{1

2}

¹ Division of Pulmonary, Critical Care, and Occupational Medicine.
² Iowa Inflammation Program University of Iowa Carver College of Medicine Iowa City, Iowa.
³ Division of Pulmonary and Critical Care Medicine.
⁴ Center for Immunology and Inflammatory Diseases Massachusetts General Hospital and Harvard Medical School Boston, Massachusetts.

No abstract available

Comment on

Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease.
Velez TE, Yoon YM, Upadhyay V, Vazquez SE, Lee CT, Selvan KC, Law CS, Blaine KM, Hollinger MK, Decker DM, Bingham GC, Pastore CF, Bonham CA, Clark MR, Schoettler NR, Strek ME, Guzy RD, Adegunsoye A, Noth I, Wolters PJ, Barker TH, Anderson MS, DeRisi JL, Shum AK, Sperling AI. Velez TE, et al. Am J Respir Crit Care Med. 2025 Oct;211(10):1823-1834. doi: 10.1164/rccm.202502-0419OC. Am J Respir Crit Care Med. 2025. PMID: 40815686

1. Raghu G, Anstrom KJ, King TE, Lasky JA, Martinez FJ, Idiopathic Pulmonary Fibrosis Clinical Research Network Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med . 2012;366:1968–1977. - PMC - PubMed
1. Misharin AV, Morales-Nebreda L, Reyfman PA, Cuda CM, Walter JM, McQuattie-Pimentel AC. et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med . 2017;214:2387–2404. - PMC - PubMed
1. Reyfman PA, Walter JM, Joshi N, Anekalla KR, McQuattie-Pimentel AC, Chiu S. et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med . 2019;199:1517–1536. - PMC - PubMed
1. Shenderov K, Collins SL, Powell JD, Horton MR. Immune dysregulation as a driver of idiopathic pulmonary fibrosis. J Clin Invest . 2021;131:e143226. - PMC - PubMed
1. Vasakova M, Selman M, Morell F, Sterclova M, Molina-Molina M, Raghu G. Hypersensitivity pneumonitis: current concepts of pathogenesis and potential targets for treatment. Am J Respir Crit Care Med . 2019;200:301–308. - PubMed